These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Use of dextropropoxyphene + acetaminophen fixed-dose combination in psychiatric hospital in Bahrain: is there a cause for concern? Al Khaja KA; Al-Haddad MK; Al-Offi AR; Abdulraheem MH; Sequeira RP Fundam Clin Pharmacol; 2009 Apr; 23(2):253-8. PubMed ID: 19645819 [TBL] [Abstract][Full Text] [Related]
26. Dextropropoxyphene: withdrawal from the US market requested: harmful drug. Prescrire Int; 2009 Aug; 18(102):166-7. PubMed ID: 19746529 [No Abstract] [Full Text] [Related]
27. Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. A pharmaceutical industry perspective on drug labeling. Robinson DS Psychopharmacol Bull; 1994; 30(1):23-5. PubMed ID: 7972625 [No Abstract] [Full Text] [Related]
29. The interaction of propoxyphene with other drugs. Rosser WW Can Med Assoc J; 1980 Jan; 122(2):149-50. PubMed ID: 7363204 [No Abstract] [Full Text] [Related]
30. Dextropropoxyphene: withdrawn in the EU. Withdrawn from pharmacies in France. Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19746528 [No Abstract] [Full Text] [Related]
31. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
32. Dextropropoxyphene: welcome withdrawal from a French hospital's formulary. Prescrire Int; 2008 Jun; 17(95):112. PubMed ID: 18629970 [TBL] [Abstract][Full Text] [Related]
33. Consumer-directed advertising of contraceptive drugs: the FDA, Depo-Provera, and product liability. Green W Food Drug Law J; 1995; 50(4):553-67. PubMed ID: 10343019 [No Abstract] [Full Text] [Related]